Pages that link to "Q46851797"
Jump to navigation
Jump to search
The following pages link to Fluoxetine promotes remission in acute experimental autoimmune encephalomyelitis in rats (Q46851797):
Displaying 13 items.
- Fluoxetine for multiple sclerosis (Q24198247) (← links)
- Selective serotonin reuptake inhibitors as a novel class of immunosuppressants (Q26829415) (← links)
- Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy (Q28395248) (← links)
- Quetiapine fumarate for the treatment of multiple sclerosis: focus on myelin repair (Q30656233) (← links)
- Fluvoxamine stimulates oligodendrogenesis of cultured neural stem cells and attenuates inflammation and demyelination in an animal model of multiple sclerosis (Q33884949) (← links)
- Fluoxetine reduces murine graft-versus-host disease by induction of T cell immunosuppression (Q37080112) (← links)
- Osteoporosis and multiple sclerosis: risk factors, pathophysiology, and therapeutic interventions (Q38215692) (← links)
- Neuroprotective arylpiperazine dopaminergic/serotonergic ligands suppress experimental autoimmune encephalomyelitis in rats (Q38863014) (← links)
- Inhibition of Acid Sphingomyelinase Allows for Selective Targeting of CD4 Conventional versus Foxp3 Regulatory T Cells (Q39379455) (← links)
- TAMEC: a new analogue of cyclomyrsinol diterpenes decreases anxiety- and depression-like behaviors in a mouse model of multiple sclerosis (Q42692147) (← links)
- Altered serotonin transporter availability in patients with multiple sclerosis (Q46573605) (← links)
- Role of Serotonin and Dopamine in Psoriasis: A Case-Control Study (Q64116789) (← links)
- Fluoxetine for multiple sclerosis (Q94398592) (← links)